Chris Degnan

Insider Reports History

Location
West Chester, PA
Signature
/s/ Jason D. Smith, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Chris Degnan:

Company Role Class Num Shares Value Price $ Report Date Ownership
UroGen Pharma Ltd. Chief Financial Officer Ordinary Shares 2,280 $38,418 $16.85 08 Oct 2025 Direct
Galera Therapeutics, Inc. Chief Financial Officer Common Stock 10,000 $10,700 $1.07 13 Mar 2023 Direct
UroGen Pharma Ltd. Chief Financial Officer Restricted Stock Units 32,609 31 Jan 2026 Direct

Insider Reports Filed by Chris Degnan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
URGN UroGen Pharma Ltd. 31 Jan 2026 1 $0 4 Chief Financial Officer 03 Feb 2026, 17:16
URGN UroGen Pharma Ltd. 08 Oct 2025 3 -$37,121 4 Chief Financial Officer 09 Oct 2025, 13:37
URGN UroGen Pharma Ltd. 08 Oct 2024 2 $0 4 Chief Financial Officer 09 Oct 2024, 16:22
URGN UroGen Pharma Ltd. 08 Oct 2024 0 $0 3 Chief Financial Officer 09 Oct 2024, 16:21
GRTX Galera Therapeutics, Inc. 13 Mar 2023 1 +$19,593 4 Chief Financial Officer 14 Mar 2023, 08:30
GRTX Galera Therapeutics, Inc. 25 Feb 2023 1 $0 4 Chief Financial Officer 28 Feb 2023, 17:57
GRTX Galera Therapeutics, Inc. 28 Feb 2022 1 $0 4 Chief Financial Officer 02 Mar 2022, 15:05